(Q39807848)

14 September 2017

title

Integrating novel primary- and secondary-prevention strategies: the next challenge for cervical cancer control (English)

1 reference

14 September 2017

main subject

cervix uterine cancer

1 reference

2

1 reference

14 September 2017

Marie-Hélène Mayrand

1

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

6

1 reference

14 September 2017

issue

11

1 reference

14 September 2017

page(s)

1725-1733

1 reference

Global cancer statistics, 2002

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Chapter 1: HPV in the etiology of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Classification of papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

The epidemiology of genital human papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

A review of human carcinogens--Part B: biological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Natural history of cervicovaginal papillomavirus infection in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Regression of low-grade squamous intra-epithelial lesions in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Process of care failures in invasive cervical cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Increased detection of epithelial cell abnormalities by liquid-based gynecologic cytology preparations. A review of accumulated data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Current cervical neoplasia screening practices of obstetrician/gynecologists in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

The health and economic effects of HPV DNA screening in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Cervical cancer screening following prophylactic human papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Diagnostic tests 2: Predictive values

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

Carcinogenicity of human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.141

21 January 2018

Identifiers

DOI

10.2217/FON.10.141

1 reference

14 September 2017

1 reference